Aurora CannabisACB -0.70%63 Market Cap is $177.2 Mil as of Jun. 24, 2026. GuruFocus rates ACB with a GF Score™ of 63/100 and a GF Value™ of $4.18 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,023 Drug Manufacturers companies, Aurora Cannabis ranks worse than 52.79% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aurora Cannabis's share price for the quarter that ended in Mar. 2026 was $3.27. Aurora Cannabis's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 58.9 Mil. Therefore, Aurora Cannabis's market cap for the quarter that ended in Mar. 2026 was $192.8 Mil.
Aurora Cannabis's quarterly market cap
declined
from Sep. 2025 ($337.2 Mil) to Dec. 2025 ($239.3 Mil) and
declined
from Dec. 2025 ($239.3 Mil) to Mar. 2026 ($192.8 Mil).
Aurora Cannabis's annual market cap
increased
from Mar. 2024 ($239.5 Mil) to Mar. 2025 ($246.9 Mil) but then
declined
from Mar. 2025 ($246.9 Mil) to Mar. 2026 ($192.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aurora Cannabis's Enterprise Value for Today is $111.5 Mil.
Aurora Cannabis (NAS:ACB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Aurora Cannabis Market Cap Related Terms
Aurora Cannabis Market Cap Historical Data
* Premium members only.
The historical data trend for Aurora Cannabis's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aurora Cannabis's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Cannabis Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aurora Cannabis's Market Cap distribution charts can be found below:
* The bar in red indicates where Aurora Cannabis's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Aurora Cannabis's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Cannabis (ACB) has a Market Cap of $177.2 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aurora Cannabis and its competitors. According to the industry distribution chart, Aurora Cannabis ranks #540 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 52.8%.
Is Aurora Cannabis' Market Cap too high?
Aurora Cannabis' current Market Cap is $177.2 Mil. The Drug Manufacturers industry median Market Cap is 207.38. Aurora Cannabis' value of $177.2 Mil is 14.6% below this industry median. Based on the distribution chart, Aurora Cannabis ranks #540 out of 1023 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aurora Cannabis has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Aurora Cannabis ranks #540 out of 1023 companies for Market Cap. This places Aurora Cannabis in the lower half of its industry. The industry median Market Cap is 207.38. Aurora Cannabis' value of $177.2 Mil is 14.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 207.38, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Cannabis's current Market Cap of $177.2 Mil is 14.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Aurora Cannabis and its competitors. For the Drug Manufacturers industry, the median Market Cap is 207.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Cannabis's current Market Cap is $177.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (ACB) is currently considered Possible Value Trap. The stock's GF Value™ is $4.18, compared to a current price of $2.83 — trading 32.3% below its estimated fair value. The current Market Cap is $177.2 Mil and 14.6% below the Drug Manufacturers industry median of 207.38. Aurora Cannabis' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Aurora Cannabis (ACB), the current Market Cap is $177.2 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Cannabis (ACB) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued.
The current stock price of $2.83 is trading 32.3% below its estimated GF Value™ of $4.18.
GuruFocus considers Aurora Cannabis to be Possible Value Trap.
Key valuation signals for ACB:
Market Cap: $177.2 Mil
GF Value™: $4.18 vs. price of $2.83 (32.3% below fair value)
Industry Position: 14.6% below the Drug Manufacturers median (#540 of 1023)
No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
63GF Score
Get the complete analysis for ACB
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACB has been successfully added to your 
